SFC
TWST icon

Strategic Financial Concepts’s Twist Bioscience TWST Stock Holding History

Strategic Financial Concepts’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-11,286
Closed -$202 – 700
2024
Q2 		$202 Buy
+11,286
New +$460K ﹤0.01% 716

Other funds holding TWST

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Strategic Financial Concepts's TWST Position: Q3 2024 in Review

Strategic Financial Concepts sold out of Twist Bioscience (TWST) in Q3 2024, closing a stake of 11,286 shares — an estimated $202 sold.

Strategic Financial Concepts first reported a position in TWST in Q2 2024 and held it in 1 quarter. The position peaked at $202 in Q2 2024. 245 funds tracked by Wall St. Rank hold TWST as of Q3 2024.

  • Strategic Financial Concepts reported no remaining Twist Bioscience position as of Q3 2024 after selling out during the quarter.
  • Strategic Financial Concepts sold 11,286 Twist Bioscience shares in Q3 2024, an estimated $202.
  • Strategic Financial Concepts first reported a position in Twist Bioscience in Q2 2024 and held it in 1 quarter.
  • Strategic Financial Concepts's Twist Bioscience position peaked at $202 in Q2 2024.
  • 245 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2024.

Based on Strategic Financial Concepts's 13F filing for Q3 2024, filed 12 Nov 2024.